Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Teva Fluticasone Propionate vs Flonase in Seasonal Allergic Rhinitis
NCT02246920Phase 3Terminated
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Mar 2014
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Teva Pharmaceutical Industries Ltd.. Started Mar 2014; status: terminated.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT02246920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02246920.